Bayer to launch Baycox Iron injection combination in Europe

Bayer launches Baycox Iron (36 mg/ml toltrazuril plus 182 mg/ml gleptoferron) suspension for injection for piglets across Europe following marketing authorization from the European Commission. Baycox Iron injection is indicated for the concurrent prevention of clinical signs of coccidiosis (such as diarrhoea) in neonatal piglets on farms with a confirmed history of coccidiosis caused by Cystoisospora suis, and the prevention of iron deficiency anaemia.

Bayer introduced the first toltrazuril based oral solution (Baycox 5%) for swine more than 20 years ago, helping farmers to prevent the clinical signs of coccidiosis (such as diarrhoea) in neonatal piglets with a single oral treatment. The latest innovation, Baycox Iron (36 mg/ml toltrazuril plus 182 mg/ml gleptoferron) suspension for injection for piglets, combines the prevention of clinical signs of coccidiosis with the prevention of iron deficiency anaemia in one easy-to-administer injection. It is available in Europe in a 100ml bottle.